A DNA topoisomerase I inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Belotecan (hydrochloride)

Item No. 35488

Technical Information
Formal Name
(4S)-4-ethyl-4-hydroxy-11-[2-[(1-methylethyl)amino]ethyl]-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, monohydrochloride
CAS Number
213819-48-8
Synonyms
  • 7-[2-(N-isopropylamino)ethyl]-(20S)-Camptothecin
  • CKD602
  • (S)-CKD602
Molecular Formula
C25H27N3O4 • HCl
Formula Weight
Purity
≥95%
Formulation
A solid
DMF: 20 mg/mlDMSO: 14 mg/mlEthanol: Slightly solublePBS (pH 7.2): 0.16 mg/ml
λmax
220, 254, 362 nm
SMILES
O=C1N2C(C3=NC4=CC=CC=C4C(CCNC(C)C)=C3C2)=CC5=C1COC([C@]5(O)CC)=O.Cl
InChi Code
InChI=1S/C25H27N3O4.ClH/c1-4-25(31)19-11-21-22-17(12-28(21)23(29)18(19)13-32-24(25)30)15(9-10-26-14(2)3)16-7-5-6-8-20(16)27-22;/h5-8,11,14,26,31H,4,9-10,12-13H2,1-3H3;1H/t25-;/m0./s1
InChi Key
SJKBXKKZBKCHET-UQIIZPHYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Belotecan is an inhibitor of DNA topoisomerase I (IC50 = 0.119 µg/ml) and a derivative of the DNA topoisomerase I inhibitor camptothecin (Item No. 11694).1 It inhibits the proliferation of various cancer cell lines, including KATO III stomach, HT-29 colon, A549 lung, MDA-MB-231 breast, and SKOV3 ovarian cancer cells (IC50s = 160, 10.9, 9, 345, and 31 ng/ml, respectively). Belotecan (150 ng/ml) induces apoptosis and cell cycle arrest at the G2/M phase in, and inhibits invasion of, SiHa cervical cancer cells.2 It reduces tumor growth in a Ca Ski cervical cancer mouse xenograft model when administered at a dose of 25 mg/kg. Belotecan (80 µg/kg) reduces food intake and body weight in pregnant dams and increases fetal deaths and decreases litter size.3 Formulations containing belotecan have been used in the treatment of ovarian and small cell lung cancer.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Lee, J.H., Lee, J.M., Kim, J.K., et alAntitumor activity of 7-[2-(N-isopropylamino)ethyl]-(20S)-camptothecin, CKD602, as a potent DNA topoisomerase I inhibitor. Arch. Pharm. Res. 21(5), 581-590 (1998).

    2. Lee, S., Ho, J.Y., Liu, J.J., et alCKD-602, a topoisomerase I inhibitor, induces apoptosis and cell-cycle arrest and inhibits invasion in cervical cancer. Mol. Med. 25(1), 23 (2019).

    3. Chung, M.-K., Kim, J.-C., and Han, S.-S. Embryotoxic effects of CKD-602, a new camptothecin anticancer agent, in rats. Reprod. Toxicol. 20(1), 165-173 (2005).